top of page

From Okinawa, Advancing
Japan’s Healthspan

TA Medical’s NMN is a high-purity, highly reliable raw material developed under a framework of scientific evidence and rigorous quality assurance.

Screenshot 2025-10-02 at 1.26.49 AM.png

TA Medical's NMN "WBNO"

One-Stop Support from NMN Raw Material Supply to Product Commercialization

TA Medical is a specialist supplier of high-purity NMN raw materials (≥99.9%), providing NMN that meets global standards of quality and safety to OEM companies and brand partners.

We offer comprehensive, end-to-end support from concept development through to product commercialization across a wide range of applications, including supplements, beverages, cosmetics, and sports products, delivering “true wellness” grounded in scientific evidence from Japan to the world.

WBNO

Screenshot 2025-10-02 at 1.26.49 AM.png

Wellness Beauty NMN Okinawa

OEM & Product Development — From Raw Materials to Market Launch

Market development

In addition to supplying NMN raw materials, we provide comprehensive support for the development of supplements, cosmetics, and functional foods. Leveraging our expertise in formulation design, encapsulation, and regulatory compliance, we support our partners in confidently bringing safe, high-quality products to market.

Screenshot 2025-12-29 at 2.40.46 PM.jpg

Scientifically Verified Quality

Quality and reliability

LGC Informed Ingredient certification (UK) includes testing for 250+ prohibited substances and audits of manufacturing control and traceability.

ISO 22000

Manufactured at a domestically certified facility compliant with the international food safety management standard

ISO 22000.

Informed Sport is an international certification program that conducts lot-by-lot testing for WADA-prohibited substances, ensuring the highest level of safety and reliability for athletes.

ISO 22000:2018 international certification obtained through audits by UK-accredited certification bodies Intertek and UKAS.

JFIC (Japan Food Inspection Corporation) is an accredited public testing institution operating under ISO/IEC 17025, specializing in safety testing for microorganisms, heavy metals, pesticides, and other contaminants.

A recommended raw material that meets the quality and safety standards established by the Japan NMN Functional Food Development Association.

JFRL (Japan Food Research Laboratories) is an internationally recognized research institution that conducts ingredient analysis, safety testing, and regulatory compliance evaluations for foods and dietary supplements.

WBNO® NMN is a high-end NMN raw material developed in pursuit of world-class purity, safety, and transparency, having met strict domestic and international standards and quality verification conducted by ISO, LGC Informed, JIHFS GMP, and JFIC/JFRL.

What Is NMN?

NMN (nicotinamide mononucleotide) is known as a compound positioned within the biochemical pathway that leads to the production of NAD⁺ (nicotinamide adenine dinucleotide) in the body, and it has been the subject of ongoing research in fundamental life science fields such as energy metabolism.

Both in Japan and internationally, academic knowledge regarding NMN and NAD⁺ is steadily accumulating, and attention is increasingly being paid to their relationship with aging and their roles within biological systems.

At TA Medical, in light of these research trends, we focus not only on the strict quality control and stable supply of high-purity NMN raw materials, but also on the provision of accurate, scientifically grounded information based on a sound scientific perspective.

NAD⁺ is widely recognized as a fundamental coenzyme essential to vital biological functions, including energy metabolism, DNA repair, and the maintenance of cellular homeostasis.

To better understand its physiological characteristics and age-related changes, knowledge has been accumulated from diverse perspectives regarding NAD⁺ level dynamics and related regulatory factors.

This graph summarizes selected findings from NAD⁺ research to provide an overview of current research trends.

NAD Graph

References

  1. Yi L, et al. (2023) – Human trial: ↑ blood NAD⁺ with oral NMN (300–900 mg, 60d).

  2. Igarashi M, et al. (2022) – Human trial: ↑ blood NAD⁺ and metabolites.

  3. Mills KF, et al. (2016) – Mouse: ↑ NAD⁺ in liver & muscle.

  4. Uddin GM, et al. (2016) – Mouse: ↑ NAD⁺ in liver & muscle (high-fat diet model).

  5. Ramanathan M, et al. (2022) – Mouse: ↑ brain NAD⁺ after oral NMN.

  6. Yamamoto T, et al. (2022) – Mouse: ↑ cardiac NAD⁺ & preserved heart function.

Best Seller

( Price shown does not include tax )
Screenshot 2025-11-14 at 6_edited.jpg

Limited-time special offer

20% Off

bottom of page